Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

4.11 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -334.326-201.592-197.723-143.883-129.068-255.131-1.288
Depreciation & Amortization 0.7950.5750.620.5210.3230.0080
Deferred Income Tax 0000-0.09596.2720
Stock Based Compensation 24.04745.02524.13316.8125.840.4060
Change In Working Capital 0-13.6445.438-27.47551.717-9.5220.215
Accounts Receivables -37.16-1.63700000
Inventory 0.836-9.44200000
Accounts Payables 34.9366.418.679-9.79124.0092.2650.225
Other Working Capital 0-8.975-3.241-17.68427.708-11.787-0.01
Other Non Cash Items 42.71432.05621.0025.4081.595131.4570.05
Operating Cash Flow -266.77-137.58-146.53-148.617-69.688-36.51-1.023
Investing Activities:
Investments In Property Plant And Equipment 0-1.634-1.041-0.328-1.04-25.250
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites -0.1350-1.179-0.33-1.185-25.1180
Investing Cash Flow -0.135-1.634-1.041-0.328-1.04-25.250
Financing Activities:
Debt Repayment 59.439.318042.7642524.851.9
Common Stock Issued 121.775155.46324.5961.2988.83191.4720.002
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 1.599172.79995.4461.9440.629279.7960.002
Financing Cash Flow 182.774367.58120.04244.708114.459304.6461.902
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -84.131228.366-27.529-104.23743.731242.8860.879
Cash At End Of Period 300.125384.256155.89183.259287.496243.7650.879